Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2007;116:463-470
Published online before print July 23, 2007, doi: 10.1161/CIRCULATIONAHA.107.706887
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
116/5/463    most recent
CIRCULATIONAHA.107.706887v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nof, E.
Right arrow Articles by Glikson, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nof, E.
Right arrow Articles by Glikson, M.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*OMIM
*UniGene
Related Collections
Right arrow Clinical genetics
Right arrow Arrythmias-basic studies
Right arrow Physiological and pathological control of gene expression
Right arrow Arrhythmias, clinical electrophysiology, drugs

(Circulation. 2007;116:463-470.)
© 2007 American Heart Association, Inc.


Arrhythmia/Electrophysiology

Point Mutation in the HCN4 Cardiac Ion Channel Pore Affecting Synthesis, Trafficking, and Functional Expression Is Associated With Familial Asymptomatic Sinus Bradycardia

Eyal Nof, MD*; David Luria, MD*; Dovrat Brass, MSc*; Dina Marek, MSc; Hadas Lahat, PhD; Haya Reznik-Wolf, PhD; Elon Pras, MD; Nathan Dascal, PhD; Michael Eldar, MD; Michael Glikson, MD

From the Heart Institute (E.N., D.L., M.E., M.G.) and Laboratory of Human Genetics (D.M., H.L., H.R.-W., E.P.), Chaim Sheba Medical Center, Tel-Hashomer; Department of Physiology and Pharmacology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv (D.B., N.D.); and Mina and Everard Goodman Faculty of Life Sciences, Bar Ilan University, Bar Ilan (D.M.), Israel.

Correspondence to Eyal Nof, MD, Heart Institute, Sheba Medical Center, Tel Hashomer 52621 Israel. E-mail ernof{at}netvision.net.il

Received April 5, 2007; accepted May 29, 2007.

Background— The hyperpolarization-activated nucleotide-gated channel-HCN4 plays a major role in the diastolic depolarization of sinus atrial node cells. Mutant HCN4 channels have been found to be associated with inherited sinus bradycardia.

Methods and Results— Sixteen members of a family with sinus bradycardia were evaluated. Evaluation included a clinical questionnaire, 12-lead ECGs, Holter monitoring, echocardiography, and treadmill exercise testing. Eight family members (5 males) were classified as affected. All affected family members were asymptomatic with normal exercise capacity during long-term follow-up. Electrophysiological testing performed on 2 affected family members confirmed significant isolated sinus node dysfunction. Segregation analysis suggested autosomal-dominant inheritance. Direct sequencing of the exons encoding HCN4 revealed a missense mutation, G480R, in the ion channel pore domain in all affected family members. Function analysis, including expression of HCN4 wild-type and G480R in Xenopus oocytes and human embryonic kidney 293 cells, revealed that mutant channels were activated at more negative voltages compared with wild-type channels. Synthesis and expression of the wild-type and mutant HCN4 channel on the plasma membrane tested in human embryonic kidney 293 cells using biotinylation and Western blot analysis demonstrated a reduction in synthesis and a trafficking defect in mutant compared with wild-type channels.

Conclusions— We describe an inherited, autosomal-dominant form of sinus node dysfunction caused by a missense mutation in the HCN4 ion channel pore. Despite its critical location, this mutation carries a favorable prognosis without the need for pacemaker implantation during long-term follow-up.


 

CLINICAL PERSPECTIVE




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Alig, L. Marger, P. Mesirca, H. Ehmke, M. E. Mangoni, and D. Isbrandt
Control of heart rate by cAMP sensitivity of HCN channels
PNAS, July 21, 2009; 106(29): 12189 - 12194.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
M. Biel, C. Wahl-Schott, S. Michalakis, and X. Zong
Hyperpolarization-Activated Cation Channels: From Genes to Function
Physiol Rev, July 1, 2009; 89(3): 847 - 885.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Biel
Cyclic Nucleotide-regulated Cation Channels
J. Biol. Chem., April 3, 2009; 284(14): 9017 - 9021.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Huang, A. Huang, Q. Zhang, Y.-C. Lin, and H.-G. Yu
Novel Mechanism for Suppression of Hyperpolarization-activated Cyclic Nucleotide-gated Pacemaker Channels by Receptor-like Tyrosine Phosphatase-{alpha}
J. Biol. Chem., October 31, 2008; 283(44): 29912 - 29919.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
M. E. Mangoni and J. Nargeot
Genesis and Regulation of the Heart Automaticity
Physiol Rev, July 1, 2008; 88(3): 919 - 982.
[Abstract] [Full Text] [PDF]